共 45 条
- [41] A Model-Based Approach to Predict Longitudinal HbA1c, Using Early Phase Glucose Data From Type 2 Diabetes Mellitus Patients After Anti-Diabetic TreatmentJOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (06) : 589 - 600Kjellsson, Maria C.Cosson, Valerie F.Mazer, Norman A.Frey, NicolasKarlsson, Mats O.
- [42] A Novel Approach Using Remote Speech Analysis In Chronic Ambulatory Heart Failure Patients Allows Early Detection Of Clinical Decompensation Leading To Hospitalization Or Unplanned Iv Diuretics Treatment Updated New DataJOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S92 - S92Amir, OfferBen-Gal, TuviaWeinstein, Jean MarcMurninkas, DanielLakobishvili, ZazaShochat, Michael KleinerDragu, RobertOuzan, ElishaLotan, ChaimEdelman, Elazer R.Anker, Stefan D.Shallom, Ilan D.Haviv, RonitPinney, Sean P.Burkhoff, DanielAbraham, William T.
- [43] Biological correlative analyses and updated clinical data of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy: CARTITUDE-2, cohort B.JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)van de Donk, Niels W. C. J.Agha, Mounzer E.Cohen, Adam D.Cohen, Yael C.Anguille, SebastienKerre, TessaRoeloffzen, WilfriedSchecter, Jordan MarkDe Braganca, Kevin C.Varsos, HelenMistry, PankajRoccia, TitoZudaire, EnriqueCorsale, ChristinaAkram, MuhammadGeng, DongNesheiwat, ToniaBubuteishvili-Pacaud, LidaSonneveld, PieterZweegman, Sonja
- [44] Development and validation of a deep learning-based model to predict response and survival of T790M mutant non-small cell lung cancer patients in early clinical phase trials using electronic medical record and pharmacokinetic dataTRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (04) : 706 - 720Lou, NingGao, RuyunXu, ChiQiao, NanJiang, JiWang, LuWang, WeicongWang, ShanboShen, WeiZheng, XinHan, Xiaohong
- [45] Phase 2 CARTITUDE-2 Study (Cohort B): Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel), a BCMA-Directed CAR-T Cell Therapy, in Patients With Multiple Myeloma (MM) and Early Relapse After Initial TherapyCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S408 - S409Agha, Mounzervan de Donk, Niels W. C. J.Cohen, Adam D.Cohen, Yael C.Anguille, SebastienKerre, TessaRoeloffzen, WilfriedSchecter, Jordan M.De Braganca, Kevin C.Varsos, HelenMistry, PankajRoccia, TitoZudaire, EnriqueCorsale, ChristinaAkram, MuhammedGeng, DongNesheiwat, ToniaPacaud, LidaSonneveld, PieterZweegman, Sonja